Shalby Limited (NSE:SHALBY) — Market Cap & Net Worth
Market Cap & Net Worth: Shalby Limited (SHALBY)
Shalby Limited (NSE:SHALBY) has a market capitalization of $197.99 Million (Rs18.31 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #16692 globally and #858 in its home market, demonstrating a -1.83% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shalby Limited's stock price Rs170.62 by its total outstanding shares 107298755 (107.30 Million). Review SHALBY current and long-term liabilities to assess the company's total debt and financial obligations.
Shalby Limited Market Cap History: 2017 to 2026
Shalby Limited's market capitalization history from 2017 to 2026. Data shows change from $241.07 Million to $197.99 Million (-3.51% CAGR).
Shalby Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shalby Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Shalby Limited's market cap is 0.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.53x
Shalby Limited's market cap is 0.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $241.07 Million | $3.25 Billion | $625.63 Million | 0.07x | 0.39x |
| 2018 | $163.57 Million | $3.83 Billion | $429.23 Million | 0.04x | 0.38x |
| 2019 | $104.47 Million | $4.61 Billion | $316.61 Million | 0.02x | 0.33x |
| 2020 | $123.20 Million | $4.87 Billion | $275.87 Million | 0.03x | 0.45x |
| 2021 | $160.67 Million | $4.31 Billion | $423.96 Million | 0.04x | 0.38x |
| 2022 | $173.13 Million | $6.99 Billion | $541.25 Million | 0.02x | 0.32x |
| 2023 | $349.64 Million | $8.05 Billion | $677.01 Million | 0.04x | 0.52x |
| 2024 | $266.48 Million | $9.34 Billion | $840.77 Million | 0.03x | 0.32x |
| 2025 | $236.64 Million | $10.87 Billion | $62.22 Million | 0.02x | 3.80x |
| 2026 | $197.99 Million | $11.41 Billion | $373.89 Million | 0.02x | 0.53x |
Competitor Companies of SHALBY by Market Capitalization
Companies near Shalby Limited in the global market cap rankings as of June 17, 2026.
Key companies related to Shalby Limited by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #329 globally with a market cap of $80.16 Billion USD.
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #999 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #1050 globally with a market cap of $25.58 Billion USD ( €21.88 Billion EUR).
- IHH Healthcare Bhd (KLSE:5225): Ranked #1344 globally with a market cap of $19.28 Billion USD ( RM76.79 Billion MYR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #329 | HCA Healthcare, Inc. | NYSE:HCA | $80.16 Billion | $389.97 |
| #999 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1050 | Fresenius SE & Co. KGaA | XETRA:FRE | $25.58 Billion | €38.85 |
| #1344 | IHH Healthcare Bhd | KLSE:5225 | $19.28 Billion | RM8.69 |
Shalby Limited Historical Marketcap From 2017 to 2026
Between 2017 and today, Shalby Limited's market cap moved from $241.07 Million to $ 197.99 Million, with a yearly change of -3.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs197.99 Million | -16.33% |
| 2025 | Rs236.64 Million | -11.20% |
| 2024 | Rs266.48 Million | -23.78% |
| 2023 | Rs349.64 Million | +101.95% |
| 2022 | Rs173.13 Million | +7.76% |
| 2021 | Rs160.67 Million | +30.42% |
| 2020 | Rs123.20 Million | +17.92% |
| 2019 | Rs104.47 Million | -36.13% |
| 2018 | Rs163.57 Million | -32.15% |
| 2017 | Rs241.07 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Shalby Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $197.99 Million USD |
| MoneyControl | $197.99 Million USD |
| MarketWatch | $197.99 Million USD |
| marketcap.company | $197.99 Million USD |
| Reuters | $197.99 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Shalby Limited
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology servic… Read more